Replies to post #9159 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Pocket, I posted this information about PLX because I felt that there were definitely some similiarities. They raised funds thru the sale of shares and have achieved success by being on the AMEX. We should be on a better exchange very soon. These aren't my words, but the words of Dr Moro. We will have to trade at a reasonable PE, but you see what happens when there are just the prospects for a possible discovery.
The thing that caught my eye was this company traded very thinnly, under 100,000 shares a day at around .60 and ran up to 58.00. Like you mentioned as did I, THEY DO NOT EVEN HAVE ANY MARKETABLE PRODUCTS AND NO REVENUE! Can it happen to Biocurex?It is entirely up to the marketing strategy and the ability to get adequate prand the proper investors. We need to spend some time and really research how this company went from obscurity to a billion dollar market cap.
Actually, I just looked at the share price today and it is up 5.00 to 44.00.

[i_invest_utrade]

Back in 2005 the cancer diagnostic market was said to reach $7.4 billion by 2009.

http://www.drugresearcher.com/news/ng.asp?id=63584-kalorama-cancer-diagnostics-microarrays

PSA tests alone run $400 million/year.

If BOCX begins being paired with PSA at a similar cost per test, then we're looking at $400 million - research costs - Abbott's cut = $$$$$.

Spread this out for every cancer diagnostic test.....